Literature DB >> 2981657

Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS.

F Fourrier, C Chopin, B Wallaert, C Mazurier, J Mangalaboyi, A Durocher.   

Abstract

Serum angiotensin converting enzyme (serum ACE) levels and plasma fibronectin levels were measured daily in 46 septic patients during a ten day period. Thirty-eight patients developed ARDS; 28 survived (group 1), ten died (group 2), eight patients had no features of ARDS and survived (group 3). Sequential measurements of ACE and fibronectin levels were compared and plotted against indexes of respiratory impairment: PaO2 max Qs/Qt, static compliance and VD/VA ratio. These indexes were taken as criteria of weaning from controlled ventilation. During ARDS (groups 1 and 2), serum ACE levels decreased and were closely correlated with the severity of lung injury. Persistently decreased levels after eight days were consistent with continuing injury or lack of endothelial repair. On the other hand, plasma fibronectin levels increased throughout the study in survivors (group 1 and 3) and decreased in the group with fatal ARDS only (group 2). These results indicate that serum ACE levels might be a good index of endothelial injury and repair during ARDS and fibronectin a better index for evolution of sepsis and vital prognosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981657     DOI: 10.1378/chest.87.2.191

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS.

Authors:  Pablo Cruces; Franco Díaz; Alonso Puga; Benjamín Erranz; Alejandro Donoso; Cristóbal Carvajal; Jan Wilhelm; Gabriela M Repetto
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

2.  Plasma fibronectin and complement following infusion of colloidal solutions after spinal anaesthesia.

Authors:  J M Vedrinne; J P Hoen; D Bussery; C Veyssere; M Richard; J Motin
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Plasma fibronectin and the critically ill.

Authors:  J K Czop
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

Review 4.  The adult respiratory distress syndrome--20 years on.

Authors:  D J Shale
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

Review 5.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

Review 6.  Genetic polymorphisms associated with acute lung injury.

Authors:  Anita J Reddy; Steven R Kleeberger
Journal:  Pharmacogenomics       Date:  2009-09       Impact factor: 2.533

7.  LPS-induced effects on angiotensin I-converting enzyme expression and shedding in human pulmonary microvascular endothelial cells.

Authors:  M I Hermanns; A M Müller; M Tsokos; C J Kirkpatrick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-29       Impact factor: 2.416

Review 8.  Coagulation inhibitor substitution during sepsis.

Authors:  F Fourrier; M Jourdain; A Tournois; C Caron; J Goudemand; C Chopin
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 9.  Advances in mechanisms of repair and remodelling in acute lung injury.

Authors:  Claudia C Dos Santos
Journal:  Intensive Care Med       Date:  2008-02-09       Impact factor: 17.440

10.  New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.

Authors:  Anderson J Ferreira; Tatiane M Murça; Rodrigo A Fraga-Silva; Carlos Henrique Castro; Mohan K Raizada; Robson A S Santos
Journal:  Int J Hypertens       Date:  2012-01-26       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.